Royal Bank of Canada »

Aclaris Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $24k 23k 1.04
2023-09-30 $92k 13k 6.94
2023-06-30 $61k 6.0k 10.24
2022-12-31 $0 7.5k 0.00
2022-09-30 $19k 831 23.26
2021-06-30 $0 3.0k 0.00
2021-03-31 $89k 3.5k 25.32
2020-12-31 $12k 1.9k 6.34
2020-09-30 $1.0k 374 2.67
2020-06-30 $7.2k 4.4k 1.63
2020-03-31 $7.9k 8.0k 0.99
2019-12-31 $7.2k 4.0k 1.79
2019-09-30 $999 645 1.55
2019-03-31 $29k 4.9k 5.91
2018-12-31 $37k 5.0k 7.41
2018-09-30 $100k 7.1k 14.14
2018-06-30 $132k 6.6k 19.99
2018-03-31 $114k 6.5k 17.49
2017-12-31 $24k 986 24.15
2016-12-31 $13k 468 27.78